摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2,2-trichloroethyloxycarbonylhydrazine | 31434-96-5

中文名称
——
中文别名
——
英文名称
2,2,2-trichloroethyloxycarbonylhydrazine
英文别名
2,2,2-trichloroethyl carbazate;2,2,2-Trichloroethyl hydrazinecarboxylate;2,2,2-trichloroethyl N-aminocarbamate
2,2,2-trichloroethyloxycarbonylhydrazine化学式
CAS
31434-96-5
化学式
C3H5Cl3N2O2
mdl
——
分子量
207.444
InChiKey
AKYVQEQYVJSLGN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    299.6±40.0 °C(Predicted)
  • 密度:
    1.617±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    64.4
  • 氢给体数:
    2
  • 氢受体数:
    3

SDS

SDS:9ad67a5ee818cf1998ebee72f87dea6b
查看

反应信息

  • 作为反应物:
    描述:
    Boc-L-蛋氨酸2,2,2-trichloroethyloxycarbonylhydrazineN,N'-二环己基碳二亚胺 作用下, 以 乙酸乙酯 为溶剂, 以88%的产率得到Boc-Met-NH-NH-Troc
    参考文献:
    名称:
    Diaz, Joseph; Guegan, Remy; Muneaux, Yvette, Bulletin de la Societe Chimique de France, 1989, # 4, p. 493 - 510
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    电化学促进醛和氨基甲酸酯的环化:获得 2-烷氧基/芳氧基-5-取代的 1,3,4-恶二唑和 1,3,4-恶二唑-2(3H)-one 衍生物
    摘要:
    通过醛的环化,开发了一种高效且环保的化学和药学上有趣的 2-烷氧基/芳氧基-1,3,4-恶二唑和 1,3,4-恶二唑-2(3 H )-酮的合成方法和卡巴酸盐。该协议涉及以电化学方式促进以良好至优异的产量获得所需产品。该方法使用 NaBr 作为电催化剂,MeOH 作为溶剂。该策略不含氧化剂和过渡金属,可在室温下无电解质完成反应。基于对照实验结果和文献报道提出了一种可能的机制。通过5-(4-chloro-3-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2( 3 H)-one,它是 Notum 羧酸酯酶活性的有效抑制剂。
    DOI:
    10.1039/d2nj04113h
点击查看最新优质反应信息

文献信息

  • Synthesis of the octadecapeptide corresponding to positions 32 to 49 of the revised amino acid sequence of thymopoietin II and its effect on low E-rosette forming cells of an aged patient with chronic renal failure.
    作者:TAKASHI ABIKO、HIROSHI SEKINO
    DOI:10.1248/cpb.30.3271
    日期:——
    The octadecapeptide, H-Arg-Lys-Asp-Val-Tyr-Val-Glu-Leu-Tyr-Leu-Gln-Ser-Leu-Thr-Ala-Leu-Lys-Arg-OH, corresponding to positions 32 to 49 of the revised amino acid sequence of bovine thymopoietin II was synthesized by the azide condensation of three fragments, (32-36), (37-41) and (42-49), followed by deprotection with hydrogen fluoride in the presence of anisole-thioanisole-o-cresol. The in vitro addition of the synthetic thymopoietin II (32-49) significantly restored the low E-rosette forming capacity of cells from an aged patient with chronic renal failure to normal levels. The in vitro effect of [Gln38, Thr43, Val47]-thymopoietin II (32-49) on the low E-rosette forming capacity of cells from the aged patient with chronic renal failure was also compared with that of the synthetic thymopoietin II (32-49). The [Gln38, Thr43, Val47]-thymopoietin II (32-49) was approximately equipotent with the synthetic thymopoietin II (32-49) at a concentration of 100 μg/ml.
    十八肽H-Arg-Lys-Asp-Val-Tyr-Val-Glu-Leu-Tyr-Leu-Gln-Ser-Leu-Thr-Ala-Leu-Lys-Arg-OH,对应于牛胸腺生成素II修订后的氨基酸序列的第32至49位,通过三个片段(32-36)、(37-41)和(42-49)的叠氮化物缩合合成,随后在茴香硫醚-邻甲酚存在下用氢氟酸脱保护。体外添加合成的胸腺生成素II(32-49)显著恢复了来自慢性肾衰竭老年患者的细胞的低E玫瑰花形成能力至正常水平。[Gln38, Thr43, Val47]胸腺生成素II(32-49)对来自慢性肾衰竭老年患者的细胞的低E玫瑰花形成能力的影响也与合成的胸腺生成素II(32-49)进行了比较。在100 μg/ml的浓度下,[Gln38, Thr43, Val47]胸腺生成素II(32-49)与合成的胸腺生成素II(32-49)大致等效。
  • A study on endocrine disorder in patients with chronic renal failure. I. Synthesis and biological activity of human gastrin I.
    作者:TAKASHI ABIKO、IKUKO ONODERA、HIROSHI SEKINO
    DOI:10.1248/cpb.30.2604
    日期:——
    A heptadecapeptide amide, H-Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2, corresponding to the entire amino acid sequence of human gastric I, was synthesized by the solution method. This peptide inhibited lactate dehydrogenase activity by 87.6% at a concentration of 300 pg/ml. This peptide was tested for suppression of PHA-induced lymphocyte proliferation, but showed no significant activity.
    一种十七肽酰胺H-Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2,对应于人胃泌素I的整个氨基酸序列,通过溶液法合成。该肽在300 pg/ml的浓度下抑制乳酸脱氢酶活性达87.6%。该肽被测试用于抑制PHA诱导的淋巴细胞增殖,但未显示出显著活性。
  • Studies on peptides. CXXVII. Synthesis of a tripentacontapeptide with epidermal growth factor activity.
    作者:KENICHI AKAJI、NOBUTAKA FUJII、HARUAKI YAJIMA、KYOZO HAYASHI、KAZUHIKO MIZUTA、MITSURU AONO、MOTOYUKI MORIGA
    DOI:10.1248/cpb.33.184
    日期:——
    The tripentacontapeptide corresponding to the entire linear sequence of epidermal growth factor was synthesized by assembling 15 peptide fragments and one His residue (position 22), followed by deprotection with trifluoromethanesulfonic acid-thioanisole in trifluoroacetic acid. The deprotected peptide was subjected to air-oxidation. After purification by ion-exchange chromatography on diethyl aminoethyl cellulose followed by high performance liquid chromatography, a peptide with powerful anti-gastric activity was obtained.
    通过组装15个肽片段和一个组氨酸残基(位置22),合成了对应于表皮生长因子整个线性序列的三十五肽。随后,通过三氟甲磺酸-噻吩在三氟乙酸中进行脱保护。脱保护的肽进行空气氧化。经过二乙氨基乙基纤维素上的离子交换色谱法纯化,接着用高效液谱法,获得了一种具有强大抗胃活性的肽。
  • Catalytic Enantioselective Amination of Enolsilanes Using <i>C</i><i><sub>2</sub></i>-Symmetric Copper(II) Complexes as Chiral Lewis Acids
    作者:David A. Evans、Douglas S. Johnson
    DOI:10.1021/ol990113r
    日期:1999.8.1
    [formula: see text] [Cu(S,S)-t-Bu-box](OTf)2 (1) catalyzes the enantioselective amination of enolsilanes with azodicarboxylate derivatives. Isomerically pure enolsilanes of aryl ketones, acylpyrroles, and thioesters added to the azo-imide in greater than 95% ee. The use of an alcohol additive was critical to achieving catalyst turnover.
    [Cu:S(S,S)-t-Bu-box](OTf)2(1)催化用偶氮二羧酸酯衍生物对烯醇硅烷的对映选择性胺化。芳族酮,酰基吡咯和硫代酸酯的异构纯烯醇硅烷以大于95%ee的量添加到偶氮酰亚胺中。醇添加剂的使用对于实现催化剂周转至关重要。
  • Studies on peptides. CIX. Synthesis of the octatriacontapeptide corresponding to positions 1 to 38 of human parathyroid hormone.
    作者:SUSUMU FUNAKOSHI、NOBUTAKA FUJII、HARUAKI YAJIMA、CHOHEI SHIGENO、ITSUO YAMAMOTO、RIKUSHI MORITA、KANJI TORIZUKA
    DOI:10.1248/cpb.30.1706
    日期:——
    The octatriacontapeptide corresponding to positions 1 to 38 of human parathyroid hormone (hPTH), a half of the whole molecule, was synthesized by assembling 9 peptide fragments in a conventional manner. Arg (mesitylene-2-sulfonyl), a new arginine derivative bearing an acid-labile protecting group, was employed in combination with a new deprotecting procedure with 1 M trifluoromethanesulfonic acid-thioanisole in TFA. The synthetic peptide exhibited an activity of 1400 IU/mg when assayed by the mouse bone adenyl cyclase activity assay.
    合成人类甲状旁腺激素(hPTH)第1到第38位的八三十肽,通过传统方法组装9个肽片段合成。使用了一种新型的精氨酸衍生物Arg(美克辛烯-2-磺酸),该衍生物具有一种酸敏感的保护基团,并结合了使用1 M三氟甲烷磺酸-硫代苯醚在TFA中进行的新脱保护工艺。合成的肽在小鼠骨腺苷酸酰化酶活性测定中表现出1400 IU/mg的活性。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物